SS

Seema Sharma

Active Director Director DIN 07347948
DIN 07347948 First appointment Nov 2015 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2015
Shareholding value •••• Premium profile

About Seema Sharma

Data last updated:

Seema Sharma is a Director at Morbocure Pharmaceuticals Private Limited (since 2015). The company operates in Trading. Morbocure Pharmaceuticals Private Limited reported revenue of ₹2.5 Lakh (FY 2024).

DIN 07347948
Primary Designation Director
Industry Trading
First Appointment 23 Nov 2015
Oldest Company Age 10 yrs
Largest company Morbocure Pharmaceuticals Private Limited · ₹2.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Nov 20152015₹2.5 Lakh (FY 2024)Active

Board colleagues of Seema Sharma

Directorship timeline

Open interactive timeline →
Morbocure Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Seema Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seema Sharma

Seema Sharma currently holds 1 directorship: Morbocure Pharmaceuticals Private Limited (Director, since 23 Nov 2015, revenue ₹2.5 Lakh (FY 2024)).

Seema Sharma was first appointed on 23 Nov 2015 as Director at Morbocure Pharmaceuticals Private Limited.

The current boards of Seema Sharma's companies include Madhav Chaturvedi (Morbocure Pharmaceuticals Private Limited), Praveen Chaturvedi (Morbocure Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available